Key Points
- Insider purchase: Johnson Matthey director Liam Condon bought 4,500 shares on June 1 at an average price of GBX 2,127, totaling about £95,715.
- Recent insider buying trend: Condon has also made two smaller purchases earlier this year, suggesting continued insider confidence in the stock.
- Analyst outlook is improving: Several firms recently lifted price targets, and the stock now carries a Moderate Buy consensus with an average target of GBX 2,298.33.
Johnson Matthey PLC (LON:JMAT - Get Free Report) insider Liam Condon bought 4,500 shares of Johnson Matthey stock in a transaction that occurred on Monday, June 1st. The stock was bought at an average price of GBX 2,127 per share, with a total value of £95,715.
Liam Condon also recently made the following trade(s):
- On Wednesday, April 15th, Liam Condon bought 12 shares of Johnson Matthey stock. The stock was bought at an average price of GBX 2,022 per share, with a total value of £242.64.
- On Wednesday, March 11th, Liam Condon bought 14 shares of Johnson Matthey stock. The stock was bought at an average price of GBX 1,941 per share, with a total value of £271.74.
Johnson Matthey Stock Up 3.0%
Shares of JMAT opened at GBX 2,184 on Wednesday. The stock has a market cap of £3.66 billion, a price-to-earnings ratio of -33.14, a P/E/G ratio of 49,242.50 and a beta of 0.91. The company has a quick ratio of 0.76, a current ratio of 1.56 and a debt-to-equity ratio of 69.69. Johnson Matthey PLC has a 12 month low of GBX 1,660 and a 12 month high of GBX 2,434. The company has a 50-day moving average price of GBX 2,037.08 and a two-hundred day moving average price of GBX 2,107.42.
Johnson Matthey (LON:JMAT - Get Free Report) last announced its quarterly earnings results on Thursday, May 28th. The company reported GBX 128.50 EPS for the quarter. The firm had revenue of GBX 1,257.30 billion during the quarter. Johnson Matthey had a negative net margin of 0.76% and a negative return on equity of 4.66%. Equities analysts predict that Johnson Matthey PLC will post 173.4112903 EPS for the current fiscal year.
Wall Street Analysts Forecast Growth
Several analysts have recently weighed in on the stock. Berenberg Bank raised their price objective on shares of Johnson Matthey from GBX 2,100 to GBX 2,300 and gave the stock a "buy" rating in a report on Monday. Deutsche Bank Aktiengesellschaft raised their price objective on shares of Johnson Matthey from GBX 2,120 to GBX 2,400 and gave the stock a "buy" rating in a report on Friday, May 29th. Jefferies Financial Group reaffirmed a "restricted" rating on shares of Johnson Matthey in a report on Friday, May 29th. Finally, UBS Group reaffirmed a "neutral" rating and set a GBX 2,200 price objective on shares of Johnson Matthey in a report on Friday, May 22nd. Three investment analysts have rated the stock with a Buy rating and two have given a Hold rating to the stock. According to data from MarketBeat.com, the company has an average rating of "Moderate Buy" and a consensus target price of GBX 2,298.33.
Read Our Latest Research Report on JMAT
Johnson Matthey Company Profile
(
Get Free Report)
Johnson Matthey is a global leader in science that enables a cleaner and healthier world. With over 200 years of sustained commitment to innovation and technological breakthroughs, they improve the function, performance and safety of their customers' products. Their science has a global impact in areas such as low emission transport, pharmaceuticals, chemical processing and making the most efficient use of the planet's natural resources. Today more than 13,000 Johnson Matthey professionals collaborate with their network of customers and partners to make a real difference to the world around us.
See Also
This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. Please send any questions or comments about this story to [email protected].
